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Fluorescent base analogues 
in gapmers enable stealth labeling 
of antisense oligonucleotide 
therapeutics
Jesper R. Nilsson1, Tom Baladi1,2,6, Audrey Gallud3,7, Dženita Baždarević4, Malin Lemurell2, 
Elin K. Esbjörner3, L. Marcus Wilhelmsson1 & Anders Dahlén5*
To expand the antisense oligonucleotide (ASO) fluorescence labeling toolbox beyond covalent 
conjugation of external dyes (e.g. ATTO-, Alexa Fluor-, or cyanine dyes), we herein explore fluorescent 
base analogues (FBAs) as a novel approach to endow fluorescent properties to ASOs. Both cytosine 
and adenine analogues (tC,  tCO, 2CNqA, and pA) were incorporated into a 16mer ASO sequence 
with a 3-10-3 cEt-DNA-cEt (cEt = constrained ethyl) gapmer design. In addition to a comprehensive 
photophysical characterization, we assess the label-induced effects on the gapmers’ RNA affinities, 
RNA-hybridized secondary structures, and knockdown efficiencies. Importantly, we find practically 
no perturbing effects for gapmers with single FBA incorporations in the biologically critical gap region 
and, except for pA, the FBAs do not affect the knockdown efficiencies. Incorporating two cytosine 
FBAs in the gap is equally well tolerated, while two adenine analogues give rise to slightly reduced 
knockdown efficiencies and what could be perturbed secondary structures. We furthermore show that 
the FBAs can be used to visualize gapmers inside live cells using fluorescence microscopy and flow 
cytometry, enabling comparative assessment of their uptake. This altogether shows that FBAs are 
functional ASO probes that provide a minimally perturbing in-sequence labeling option for this highly 
relevant drug modality.
The seminal work on antisense technology emerging in the late  1970s1,2, along with the advancement in funda-
mental understanding of the regulatory processes of ribonucleic acids (RNAs) occurring over the past two dec-
ades, have set the stage for therapeutic intervention at the translational  level3–5. This has enabled the development 
of several novel oligonucleotide-based (ON) therapeutics, such as small interfering RNAs (siRNAs) and antisense 
oligonucleotides (ASOs), capable of modulating the expression of disease-associated  genes6,7. A particularly 
attractive ASO design, owing to its catalytic mode of action, reasonably straightforward design, and potential 
for gymnotic delivery, is the  gapmer4,8. Gapmers are typically single-stranded, short (16–20 nucleotides (nt)), 
synthetic ASOs with an 8–10 nt DNA stretch in the middle of the sequence, termed “the gap”, which is flanked 
on both sides by “wings” consisting of 1–5 modified nucleotides, which provide improved nuclease stability 
and additional RNA affinity. Gapmers induce their pharmacological effect by associating to the complementary 
RNA target through Watson–Crick base-pairing. This initiates recruitment of endonuclease RNase H1, which 
selectively cleaves the RNA strand of the hybrid duplex, allowing the intact gapmer to continue its catalytic 
cycle. In addition to the recently developed RNA vaccines for combating the SARS CoV-2 pandemic, a total of 
ten ON drugs have been approved by the U.S. Food and Drug Administration and/or the European Medicines 
 Agency9. Gapmers currently constitute a majority of the approved therapeutics on this list, which underlines 
their importance in this field.
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Fluorescence-based techniques are invaluable tools for direct and detailed visualization of dynamic biomo-
lecular interactions in live cells and tissue. This has enabled studies of several aspects that are central to ASO 
development, including cellular uptake, trafficking, and protein  interactions10–12. The currently favored approach 
for introducing fluorescent labels to ASOs is by covalent conjugation of fluorophores, such as ATTO-, Alexa 
Fluor-, or cyanine (Cy) dyes, to the end of the oligonucleotide. Although this external end-labeling scheme typi-
cally renders the gapmer highly emissive, the significant size, amphiphilicity, and/or additional charges associated 
with the fluorophores can be problematic as they may affect properties that are critical to the gapmer’s therapeutic 
performance, including the affinity to the target RNA and/or interactions with RNase H1, and may also affect 
the affinity to lipid structures. Label-induced perturbations of the properties of therapeutic oligomers have 
indeed been  reported13–15. Edelson et al. for instance, showed that the propensity of DNA-targeting oligomer-
fluorophore conjugates to enter cell nuclei varied substantially depending on the identity of the fluorophore and 
characteristics of the linker  chemistry15. Furthermore, affinity studies of short Cy5-labeled DNAs have shown 
that the presence of the fluorophore, which in the case of Cy5 is one of the most widely used for ASO labeling, 
affects the thermodynamic stability of the resulting DNA  duplex16,17. There have also been accounts that highlight 
the need to consider lipophilicity when selecting a fluorescent label, by showing that the lipid bilayer affinity of 
common water-soluble dyes can differ  dramatically18.
A conceptually different approach to achieve fluorescent ASOs would be to incorporate fluorescent base 
analogues (FBAs) as an integral part of the oligonucleotide structure. FBAs are synthetic nucleobases typically 
designed to be both structural and functional analogues of their canonical counterpart, with the added value of 
being significantly  fluorescent19–21. Therefore, FBA-containing oligonucleotides largely retain their native base-
pairing, duplex stability, and secondary structure without introducing significant steric bulk to the oligomer. A 
unique and attractive feature inherent to FBA labeling is that the fluorophore is firmly located in the oligomer 
stack, which allows for positioning of the label at a specific site of interest with a level of spatial control that is not 
attainable with external fluorophores. FBAs have previously been employed as oligomer-incorporated report-
ers to study DNA duplex-22, triplex-23, and G-quadruplex24 formation, as well as in Förster resonance energy 
transfer (FRET) applications to monitor ligand  binding25,26, duplex form  transitions27,28, and protein-nucleic 
acid  interactions29,30. These studies and others have provided important novel insights on isolated biological 
systems, while there is a notable lack of FBA applications in more complex biological matrixes. In fact, the first 
report where an FBA was used to achieve fluorescent properties in live cells was recently published by us, where 
we demonstrated the applicability of the cytosine analogue  tCO for studying delivery of functional mRNA to 
human  cells31.
In this work, we continue our development of FBAs as internal fluorescent labels in ON therapeutics by 
exploring them as an alternative way of achieving fluorescent ASOs, with the added value of in-sequence posi-
tioning with maintained canonical base-pairing. We perform a comprehensive photophysical characterization, 
which is essential for accurate interpretation of fluorescence-based data (e.g. from live cell microscopy studies), 
and study how different FBAs, and positions in the gapmer sequence, affect their RNA target affinities, secondary 
structures, knockdown activities, and uptake characteristics. The study includes the tricyclic cytosine analogues 
 tC32 and  tCO33, as well as the more recently developed quadracyclic adenine analogue  2CNqA34, and pentacyclic 
adenine analogue  pA35 (Fig. 1a), all of which were incorporated into a 16 nt gapmer sequence (Fig. 1b) targeting 
the long non-coding RNA Metastasis Associated Lung Adenocarcinoma Transcript 1 (MALAT1)36.
The FBAs included in this work have previously been characterized as  monomers33,35,37–39, as well as inside 
 RNA34,40 and/or  DNA32,33,41,42, where they exhibit excellent base-mimicking and emissive properties. MALAT1 
is ubiquitously expressed and highly abundant in the nucleus; it is involved in multiple pathological processes, 
including tumor progression and metastasis, and has consequently been targeted for silencing by several ASO 
therapies, including  gapmers43 and gapmer  conjugates44–46. The gapmer sequence and design used here (Fig. 1b) 
were developed in a previous  study46 and the modifications, i.e. the 2’-4’-ethylenoxy-bridged ribose (or con‑
strained ethyl, cEt) wings and phosphorothioate (PS) linkages, are widely used in the field to improve ASO 
stability, potency, and  bioavailability47,48. In this work, we show that the combined base-mimicking and emissive 
properties of the investigated FBAs, as established in RNA and/or DNA, largely extends to the gapmer environ-
ment, and demonstrate their usefulness as fluorescent probes in live cells using fluorescence microscopy and 
flow cytometry. The FBA labeling approach thus opens new avenues for studying ASOs and provides a powerful 
alternative to external labels for fluorescence-based investigations where a native behavior is key.
Material and methods
Oligonucleotide synthesis. Gapmers were synthesized on a 16 or 32 μmol scale on an ÄKTA Oligopilot 
10 system using PS 5G UnyLinker support (GE Healthcare, 347 μmol/g). All DNA phosphoramidites were pur-
chased from Sigma Aldrich. All cEt phosphoramidites were obtained from Pharmaron. The 5’-amino-modifier 
C6 was obtained from GlenResearch. FBA phosphoramidites were prepared as described in the literature  (tC49, 
 2CNqA34,  pA35) and/or acquired from GlenResearch (tC,  tCO). Phosphoramidites were dissolved to a final con-
centration to 0.1 M (3 equivalents) in DNA-grade acetonitrile (ACN) prior to use. Detritylation was performed 
using 3 vol-% dichloroacetic acid in toluene. 5-(benzylthio)-1H-tetrazole (BTT) was used as activating agent 
(0.3 M in ACN) for the couplings. Recirculation times of phosphoramidites were 5 min for DNA building blocks, 
10 min for 2’-cEt building blocks, and 40 min for the FBA and 5’-amino-modifier C6 building blocks. Pheny-
lacetyl disulfide (PADS) was dissolved in a 50 vol-% solution of 3-picoline in ACN (0.2 M) and aged for 24 h 
before use. Equal volumes of Cap A (9.1 vol-% acetic anhydride in tetrahydrofuran (THF)) and Cap B (THF/N-
methylimidazole/pyridine 80:10:10 vol-%) were mixed in situ for capping. Cyanoethyl backbone removal was 
performed with 20 vol-% diethylamine in ACN after a final 5’-detritylation. Gapmers were cleaved from the 
solid support and further deprotected by treatment with aqueous ammonia (26 mass-%) at 55 °C for 15–20 h and 
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were subsequently purified using ion-pairing HPLC on reverse phase columns. The gapmers labeled with Cy3 
were synthesized as above, with the exception that they were purified with the 5’-monomethoxytrityl (MMT) 
protecting group on. After removal of the MMT group, the free 5’-NH2 was reacted with NHS-activated 4-azi-
dobutanoic acid and further conjugated to Cy3-dibenzocyclooctyne (Cy3-DBCO, Sigma) via strain-promoted 
azide-alkyne cycloaddition (SPAAC, Supplementary Fig. S14). HPLC and HRMS data for all synthesized gap-
mers are provided in Supplementary Figs. S1–S13 and S15–S16). UV purities were determined using ion-pairing 
LCMS and are stated at 260 nm. Yields are given based on the initial resin loading and gapmer content of the 
final product, as calculated from UV absorption.
Spectroscopic characterization. Sample preparation and general information. The spectroscopic char-
acterization was carried out at room temperature (RT, ca. 22 °C) in 10 mM RNase-free phosphate buffer (pH 7.4) 
containing 1.0 mM EDTA and 100 mM added NaCl. Concentrations of single-stranded gapmers and/or RNA 
were determined spectroscopically using the Lambert–Beer equation. The molar absorptivities at 260 nm, of 
single-stranded oligomers (εO, unit: L[mol  oligomer]-1  cm-1), were calculated based on nucleobase composition 
according to:
with each nucleotide contributing with the following molar absorption coefficients (εN): adenine: 15,300  M−1  cm−1, 
thymine or uracil: 9300  M−1 cm–−1, guanine: 11,800  M−1  cm−1, cytosine 7,400  M−1  cm−1, tC: 13,500  M−1  cm−1, 
 tCO: 11,000  M−1  cm−1, 2CNqA: 14,600  M−1  cm−1, pA: 22,300  M−1  cm−1. A factor of 0.9 was applied to account for 
the hypochromic base stacking effect. The concentration of the Cy3-labeled oligomer was determined using the 
molar absorptivity for the Cy3 band (εCy3 = 151,000  M-1  cm-1 at 553 nm, as provided by Sigma). Gapmer:RNA 
duplexes were afforded by first mixing the single-strands at RT, then annealing them in solution using the fol-
lowing temperature program: RT to 85 °C at 4 °C/min, remain at 85 °C for 15 min, 85 °C to RT at 1.5 °C/min.
UV–vis absorption spectra. Absorption spectra were recorded on a Cary 4000 or Cary 5000 (Varian Technolo-
gies) spectrophotometer using a 1.0 nm wavelength interval (spectral band width (SBW): 1–2 nm, integration 
time: 0.05–0.1 s, optical path length: 3.0 mm). All spectra were baseline corrected by subtracting the correspond-
ing absorption from the solvent only.
Steady‑state emission spectra. Emission spectra were recorded on a SPEX Fluorolog (Jobin Yvon Horiba) fluor-
imeter. Samples were excited at 345 nm (tC-2, tC-2w, tC-3), 350 nm (tC-1,  tCO-1,  tCO-2, 2CNqA-1, 2CNqA-2, 




Figure 1.  (a) Two fluorescent base analogues from the tricyclic cytosine family (tC and  tCO) and two adenine 
analogues (2CNqA and pA) were used in this study; R = deoxyribose. (b) Sequence and chemistry of the 
MALAT1-targeting gapmer (U) explored in this study. The three flanking bases on each side (wings, bold font) 
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(integration time: 0.05–0.1 s, optical path length: 3.0 mm) and monochromator slits adjusted to achieve optimal 
signal output, resulting in SBWs in the interval 1.0–2.8 nm on both the excitation and emission side. Emission 
spectra were corrected for Raman scattering by subtracting the corresponding emission from the solvent only.
Fluorescence quantum yield determinations. Fluorescence quantum yield (ΦF) determinations were per-
formed using a duplex- or single-strand concentration of 9.5 µM (± 0.5 µM) and 60–100 µL sample volume in 
a 3.0 mm × 3.0 mm path length quartz cuvette. For the duplex samples (the RNA-bound gapmers), a 30–40% 
molar excess of RNA was applied to promote full hybridization. For the FBA-labeled gapmers, ΦF was deter-
mined relative to a solution of quinine sulphate (Sigma) in 0.5 M  H2SO4 (ΦF,REF = 55%50). For the Cy3-labeled 
gapmer, a solution of Rhodamine 6G (Sigma) in ethanol (ΦF,REF = 95%50) was used. Quantum yields were calcu-
lated according to:
where  IS(λ) and  IREF(λ) denote the emission intensity of the sample and reference, respectively. The absorption 
at the excitation wavelength for the samples  (AS) and reference  (AREF) under the applied conditions were in the 
interval 0.004–0.05, to ensure negligible inner filter effects. The adopted solvent refractive index for the sample 
was ηS = 1.333 (phosphate buffer), while the corresponding values for the references were ηREF = 1.339 (for 0.5 M 
 H2SO4) and ηREF = 1.360 (for ethanol). The reported quantum yields are given as mean ± standard deviation of 
two independent replicates.
Fluorescence lifetime measurements. Fluorescence lifetimes were determined with time-correlated single pho-
ton counting using identical sample conditions as in the quantum yield determination (vide supra). The FBA-
labeled gapmers were excited using an LDH-P–C-375 (PicoQuant) pulsed laser diode with emission centered 
at 377 nm; full width half max (FWHM) of the pulse were ca. 1 nm and 70 ps with respect to wavelength and 
time, respectively. The Cy3-labeled gapmer was excited using an LDH-D-TA-560 (PicoQuant) pulsed laser diode 
with emission centered at 560 nm; FWHM of the pulse were ca. 0.5 nm and 40 ps with respect to wavelength 
and time, respectively. The laser diodes were powered by a PDL 800-B (PicoQuant) laser driver delivering light 
pulses at a frequency of 10 MHz. Sample emission was collected at a right angle, through an emission polarizer 
set at 54.9° (magic angle detection) and observed at λmax of the sample emission (± 10 nm) with a 10 nm SBW. 
Photon counts were recorded on a R3809U-50 microchannel plate PMT (Hamamatsu) and fed into a LifeSpec 
multichannel analyzer (Edinburgh Analytical Instruments) with 1024 or 2048 channels (at 20–50 ps/channel 
resolution) until the stop condition of  104 counts in the top channel was met. The instrument response function 
(IRF) was determined using a frosted glass (scattering) insert. The reported amplitude-averaged lifetimes are 
given as mean ± standard deviation of two independent replicates. Details on data fitting and calculation of aver-
age lifetimes are provided in Supplementary Sect. 2.4 and Table S1.
Absorption monitored gapmer:RNA duplex melting. Melting of the gapmer:RNA duplexes was performed at 
4 µM duplex concentration using equimolar amounts (± 10%) of gapmer and RNA at a sample volume of 1 mL 
(± 10%). The melting was performed using a Cary 4000 or Cary 5000 (Varian Technologies) UV–vis spectropho-
tometer equipped with a Peltier unit for temperature control, by ramping the temperature from 20 °C to 85 °C 
at a rate of 1.0 °C/min, then holding at 85 °C for 5.0 min, then returning to 20 °C at a rate of 1.0 °C/min. This 
cycle was repeated twice (i.e. four melting transitions). Absorption at 260 nm was collected at 1.0 °C intervals 
(SBW: 2 nm, integration time: 2.0 s, optical path length: 4.0 mm) throughout the temperature program. After 
processing the absorption (A) vs. temperature (T) data with a five-point Savitzky-Golay smoothing function, the 
melting temperature  (Tm) was calculated as the mean ± standard deviation of the zero-intercepts of the second 
derivative  (d2A/dT2 = 0) for the four melting transitions.
Circular dichroism (CD). The CD spectra and CD-monitored melting of gapmer:RNA duplexes were performed 
using identical sample conditions as in the absorption melting (vide supra), on a Chirascan CD spectrometer 
(Applied Photophysics) equipped with a Peltier unit for temperature control. The spectra were recorded with a 
1.0 nm wavelength interval (integration time: 0.3 s, optical path length: 4.0 mm, SBW: 1 nm) in two sequential 
repeats. The repeats were then averaged, and the corresponding spectrum of the solvent was subtracted. The 
temperature cycling was performed between 10 °C and 80 °C in steps of 5 °C or 10 °C, with a 5 min hold time 
at each temperature to allow for equilibrium to set. The CD melting temperature was determined as the inflec-
tion point of the Boltzmann sigmoid fits of the CD vs. T data (Supplementary Fig. S20) and presented as the 
mean ± standard deviation of the  Tm for the two melting transitions. For the A-form CD spectrum presented in 
Fig. 2b, the following RNA sequence (hybridized to its complimentary RNA strand) was used: 5’-CGA CAC ACA 
CAA GGA CGA GGA UUC C-3’.
Real-time polymerase chain reaction (qPCR) for MALAT1 knockdown. Cell culture. HEK 293 
cells stably overexpressing glucagon-like peptide 1 receptor (HEK 293-GLP1R) were cultured in Dulbecco’s 
modified eagle medium (Gibco, 31,966) containing 10% fetal bovine serum (Gibco, 10,270) and 100  µg/ml 
hygromycin B (Invitrogen, 10,687) and were maintained at 37 °C in a humidified atmosphere containing 5% 
 CO2, 21%  O2.
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Cell lysis, reverse transcription, and real‑time polymerase chain reaction. For knockdown analysis of the gap-
mers, 384-well plates coated with Poly-D-Lysin (Corning, 354,663) were seeded with 7,000 HEK 293-GLP1R 
cells in 35 µL per well. Twenty-four hours later, the cells were treated with gapmers at indicated concentrations 
(14 points, 1:3 dilution dose–response for each gapmer) in duplicate. Twenty-four hours later, the gapmer-con-
taining medium was removed from the wells, and the cells were washed once with Dulbecco’s phosphate buffer 
saline (Gibco,14,040). Cell lysis was performed by adding 30 µL lysis buffer composed of RLN lysis buffer (Qia-
gen, 74,182) and 4% RNAsecure RNase Inactivation Reagent (ThermoFisher, AM7006) to the wells. Lysates were 
transferred from the cell plate to a PCR plate (Axygen, PCR-384-RGD-C) containing Cells-to-CT Reagents for 
reverse transcription reaction (ThermoFisher, 4391852C), making the lysate 10% of the total volume. The result-
ing cDNA samples were then diluted 1:16 in master mix solutions containing hydrolysis probes for MALAT1 
(Applied Biosystems, Hs00273907_s1) or HPRT1 (Applied Biosystems, Hs02800695_m1). Real-time PCR reac-
tions were run on QuantStudio 7 Flex Real-Time PCR System (Applied Biosystems). Further details on how 
the reverse transcription reaction and real-time PCR reaction were performed can be found in Stulz et al51. The 
relative mRNA expression levels for MALAT1 were calculated by normalizing the MALAT1 expression levels to 
those of the reference gene HPRT1, ( 2−Cq , where ΔCq is the difference in expression). The relative expression 
values were then normalized to the corresponding values from the negative control (untreated cells), for each 
gapmer. The dose–response fitting procedure is described in supplementary Sect. 3.3.
Fluorescence microscopy, flow cytometry, and cytotoxicity. Cell culture. Wild-type HEK 293T 
cells were purchased from ATCC® and cultured at 37 °C and 5%  CO2 in complete medium composed of DMEM 
GlutaMax low-glucose (Gibco, 21,885,025), with an addition of 10% fetal bovine serum (Gibco, 10,270,106). Dur-
ing dissociation/sub-cultivation, the cells were washed with DPBS calcium/magnesium free (Gibco, 14,190,250) 
and exposed to Trypsin-0.25% EDTA. Cells were tested and confirmed to be mycoplasma free.
Fluorescence microscopy. The cells were seeded in a CELLview™ glass-bottom quartering cell culture dishes 
(Greiner Bio-One, 627,870) at a density of 0.18 million cells/mL with 250 µL per compartment one day prior 
exposure. Cells were exposed to the gapmers for 24 h, at a final concentration of 3 µM in cell culture medium. 
Confocal images were acquired on live cells using an inverted Nikon C2 + confocal microscope equipped with 
a C2-DUVB GaAsP Detector Unit with variable emission bandpass, and an oil-immersion 60 × 1.4 Nikon APO 
objective. (Nikon Instruments, Amsterdam, Netherlands). The fluorescence was detected between 407–700 nm 
for the FBAs (following excitation with the 405 nm laser line) and 563–700 nm for Cy3 (exc. 561 nm), with the 
pinhole aperture was set at 1 Airy unit. All images were equally processed using ImageJ 1.53c52 and the corre-
sponding unadjusted images are provided in Supplementary Fig. S27.
Flow cytometry. Cells were seeded in flat-bottom 96-well plates (VWR, 734–2327) at a density of 0.18 mil-
lion cells/mL with 100 µL/well one day prior to exposure. Cells were exposed to gapmers at doses up to 3 µM 
(6 points: 1:3 dilution steps). Twenty-four hours after treatment the supernatants were collected and cells were 
washed with DPBS, dissociated using TrypLE™ Express (12,604,021), and resuspended in DPBS with 5% FBS. 
Cell samples were transferred to round bottom 96-well plates and analyzed on a BD LSRFortessa™ flow cytom-
eter (BD Instruments). Debris were excluded from the analysis by plotting the forward scatter (FSC) vs. side 
scatter (SSC) with all events and gating for living cells. Cell aggregates (dividing cells and cell clusters) were 
excluded by plotting the SSC-height vs. SSC-area with living cells and gating for single cells. Cells were excited 
with 405 nm laser light, where after intracellular FBA mean fluorescence intensities were detected and treated as 
described in supplementary Sect. 3.5. Experiments were performed in biological duplicates with three technical 
replicates per biological replicate.
Cytotoxicity. Cell membrane integrity was evaluated using the CyQUANT™ LDH Cytotoxicity Assay (Thermo 
Scientific, C20300) according to the manufacturer’s instructions. Briefly, reduced lactate dehydrogenase (LDH) 
released in the supernatants of cells exposed to gapmers for 24 h was measured using a coupled enzymatic assay 
which results in the conversion of a tetrazolium salt into a red formazan product. The product absorption was 
recorded at 490 nm and 680 nm. The toxicity was expressed as the percentage of LDH release in supernatant 
compared to maximum LDH release (supernatant + cell lysate) and the normalized fraction of cell death was 
calculated by dividing the LDH values by the corresponding values from lysed untreated cells.
Results and discussion
Target affinity, knockdown efficiency, and secondary structure of the gapmers. Target affinity 
and MALAT1 knockdown. We opted for using tC to explore the impact of different labeling positions in the 
gapmer, due to its robust fluorescence and cytosine-mimicking properties reported in a variety of nucleic acid 
 surroundings41,42. We synthesized four sequences with different tC substitution patterns (tC-1, tC-2, tC-2w, and 
tC-3, Table 1) and tested their affinity to the fully complementary RNA target sequence (T, Table 1) using UV-
monitored melting experiments as well as MALAT1 knockdown efficiency in HEK 293-GLP1R cells using a 
direct lysis real-time polymerase chain reaction (qPCR) assay.
The melting temperature  (Tm) of the unmodified gapmer (U, Table 1) with its complementary RNA T was 
determined to be 61.5 ± 0.4 °C and, like all gapmers included in this study, it displays a distinct two-state melting 
behavior (Supplementary Fig. S21 and Table S3). It has previously been shown that the effect on  Tm of substitut-
ing canonical bases for FBAs typically depends on the neighboring bases in the oligonucleotide; for example, 
tC substitution in 10mer DNA renders a ΔTm of 5 °C for TT neighbors, but − 1 °C for GA  neighbours42, which 
are the positions for the cytosine analogues in this work. Here, we observe a small but consistent destabilizing 
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effect on the gapmer:RNA duplex for all combinations of tC incorporations in the gapmers, with ΔTm ranging 
from − 0.8 to − 5.3 °C (Table 1). Because the FBA phosphoramidites we used to synthesize the gapmers have 
deoxyribose sugars instead of an affinity-promoting  cEt48, the introduction of a tC in the wing, like for tC-3 and 
tC-2w, effectively replaces one cEt sugar with a deoxyribose in the gapmer. To isolate this feature, we synthesized 
the control gapmer  Uw, which is identical to the unmodified gapmer U apart from having a deoxyribose in posi-
tion 2. The observed negative ΔTm for  Uw (− 1.7 °C) suggests that the reduced affinity for tC-3 and tC-2w in part, 
but not fully, can be attributed to the removal of a cEt sugar. We thereafter tested the knockdown efficiency of 
the tC-containing gapmers. The unmodified gapmer U has a  pEC50 of − 5.7 ± 0.2 (Table 1, see Supplementary 
Figs. S22–S23 and Table S4 for dose–response data; unit for  EC50: M), and we found that tC modifications barely 
affect the gapmer activity (ΔpEC50 = 0.2–0.3), with no apparent differences between tCs positioned in the wings 
and gap of the sequence.
We next explored the other types of FBAs and decided to challenge our in-sequence labeling approach by 
incorporating them in the biologically critical gap region, rather than in the wing of the gapmer. This led to the 
synthesis of gapmers containing one or two incorporations of  tCO, 2CNqA, or pA in the gap, as shown in Table 1. 
The ΔTm observed for the gap-labeled sequences is consistently small; the most extreme effect being an increase of 
ca. 4 °C, as seen for 2CNqA-2 and pA-1TA, which is in line with the corresponding behavior reported for 2CNqA 
and pA in 10mer  DNA34,35. The knockdown efficiency of the FBA gapmers were similar to that of the unmodi-
fied gapmer for sequences containing  tCO (ΔpEC50 = 0.1–0.2), while 2CNqA-2 and the pA-containing gapmers 
exhibited a reduced activity (ΔpEC50 = 0.5–0.6).This was especially apparent for pA-2, for which a full response 
curve could not be captured in the assayed dose range (Supplementary Fig. S22). Although gapmer-induced gene 
knockdown involves several interlaced processes, including uptake, RNA binding, and RNase H1 processing, 
it is tempting to ascribe the reduced activity of in particular 2CNqA-2 and pA-2 to their fairly sizeable quadra- 
and pentacyclic ring systems, respectively, in combination with the proximity of the FBA moieties in the gap. 
For comparison, we included a Cy3 end-labeled gapmer in this study (Cy3, Table 1). We note that the presence 
of the fluorophore in this position has a negligible effect on the gapmer:RNA duplex stability (ΔTm = 0.5 °C) but 
that it reduces the knockdown efficiency slightly (ΔpEC50 = 0.4).
Secondary structure of gapmer:RNA duplexes. To investigate the effect of FBA incorporation on gapmer:RNA 
secondary structure, we measured circular dichroism (CD) of the gapmers hybridized to the RNA target 
sequence T.
The resulting CD spectra (Fig. 2) are dominated by strong positive bands at ca. 265 nm and weak negative 
bands at ca. 240 nm, which closely resembles the features of locked nucleic acid:RNA  duplexes53,54. We also note 
Table 1.  Gapmer sequences, gapmer:RNA melting temperatures, and knockdown efficiencies, relative to 
their unmodified counterpart U. Bold font denotes cEt sugars; all gapmers have phosphorothioate backbones 
throughout the sequence. a The sugar moiety in the FBA nucleotides is deoxyribose. b Difference in melting 
temperature compared to the unmodified gapmer U  (Tm(U) = 61.5 ± 0.4 °C) in 10 mM phosphate buffer (pH 
7.4) with 100 mM NaCl and 1.0 mM EDTA added, mean ± standard deviation of four melting transitions. 
c Difference in effective MALAT1 knockdown concentration compared to the unmodified gapmer U 
 (pEC50(U) = − 5.7 ± 0.2,  EC50 unit: M), mean ± standard deviation of duplicate biological replicates run on at 
least two occasions. d Gapmer  Uw, having one deoxyribose sugar in position 2, was included as a control for the 
wing-labeled FBA-gapmers tC-2w and tC-3. e Unsatisfactory fit due to incomplete knockdown in the applied 
concentration range, see Supplementary Fig. S22. f Unable to fit data. g Cy3 was conjugated to the 5’ end of the 
gapmer via a DBCO-type click linker (Supplementary Fig. S14). h The Cy3 gapmer was evaluated in a biological 
duplicate on one occasion and the  pEC50 was referenced to the unmodified gapmer U included in the same 
experiment (Supplementary Fig. S23). i Target sequence, all RNA.
Oligomer 5’–3’ Sequence (X =  FBAa) Fluorescent label ΔTm (°C)b ΔpEC50 (log(M))c
U GCA TTC TAA TAGC AGC – 0 ± 0.5 0 ± 0.3
Uw GCATTC TAA TAGC AGC d – − 1.7 ± 0.5 − 0.01 ± 0.3
tC-1 GCA TTC TAA TAG XAGC tC − 1.8 ± 0.5 0.2 ± 0.4
tC-2 GCA TTXTAA TAG XAGC tC − 0.8 ± 0.7 0.3 ± 0.4
tC-2w GXATTC TAA TAG XAGC tC − 5.3 ± 0.8 0.3 ± 0.4
tC-3 GXATTXTAA TAG XAGC tC − 3.7 ± 0.5 0.3 ± 0.4
tCO-1 GCA TTC TAA TAG XAGC tCO − 1.6 ± 0.4 0.2 ± 0.4
tCO-2 GCA TTXTAA TAG XAGC tCO 0.9 ± 0.4 0.1 ± 0.4
2CNqA-1 GCA TTC TAA TXGCAGC 2CNqA 2.0 ± 0.4 0.1 ± 0.3
2CNqA-2 GCA TTCT XATXGCAGC 2CNqA 4.0 ± 0.4 0.6 ± 0.4
pA-1TG GCA TTC TAA TXGCAGC pA − 0.9 ± 0.4 0.6 ± 1.5e
pA-1TA GCA TTCT XATAGC AGC pA 3.6 ± 0.4 0.5 ± 0.3e
pA-2 GCA TTCT XATXGCAGC pA − 0.1 ± 0.4 –f
Cy3 Cy3-TCA GCA TTC TAA TAGC AGC g Cy3 0.5 ± 0.4 0.4 ± 0.7 h
T GCU GCU AUU AGA AUGC i – n.a n.a
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that the spectra share common features with the RNA homoduplex spectrum, most notably the strong band at 
265 nm (Fig. 2b), which agrees with the reported notion that RNA forms duplexes that are predominantly A-form 
when hybridized with a DNA strand containing locked  nucleotides55. Induced CD, which may arise as a result of 
incorporating FBAs into nucleic acid structures, was not observed, as evidence by the lack of spectral features in 
the 330–420 nm region (Fig. 2, insets). We conclude that all single-labeled gapmers, including Cy3, give rise to 
CD spectra that closely resemble that of the unmodified gapmer U (Fig. 2a), which suggests that the fluorophores 
do not perturb the secondary structure of the hybrid duplex. This is also true for the double-labeled gapmers, 
with the exceptions of 2CNqA-2 and in particular pA-2, which both have slightly deviating CD signatures in the 
280–340 nm region (Fig. 2b). This is interesting in relation to their reduced knockdown efficiency (vide supra), 
suggesting that the interactions between the RNase H1 and gapmer:RNA duplexes could be compromised when 
the two adenine FBAs are positioned close to each other in the gap. In addition to the CD spectra shown in Fig. 2, 
the temperature dependence of the CD for all gapmers are provided in Supplementary Fig. S20 and Table S2. As 
expected, we observe the same two-state hybridization behavior as in the corresponding isotropic absorption 
melting experiment, and the  Tm data extracted from the CD support the trend seen in the UV absorption data.
Photophysical properties of the labeled gapmers. Understanding the photophysical properties of a 
fluorophore is essential for accurate interpretation of the behavior of the labeled oligonucleotide and for assess-
ing compatibility with other fluorescence- and microscopy-based applications. To facilitate this, we conducted a 
thorough assessment of the modified gapmers, examining their spectral characteristics and fluorescence quan-
tum yields (ΦF) using UV–vis- and fluorescence spectroscopy, as well as fluorescence lifetimes (τF) using time-
correlated single photon counting (TCSPC).
Figure 2.  Circular dichroism (CD) spectra of tC (green),  tCO (red), 2CNqA (blue), pA (dark gray), Cy3 (violet), 
and unmodified U (black dotted line) gapmers hybridized to the RNA target T. The duplex concentration was 
4 µM and the spectra were collected at 10–15 °C to ensure full hybridization. Insets: A zoom-out indicating the 
region (black rectangle) of the main figure. (a) Single-labeled gapmers. (b) Double-labeled gapmers. To illustrate 
the similarity to the A-form CD signature, an RNA:RNA duplex (red dashed line, normalized, see Material and 
Methods section for sequence) is included.
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Single‑stranded gapmers. The absorption spectra of the FBA-labeled gapmers are characterized by bands 
centered at ca. 260 nm, corresponding to the absorption of the canonical nucleobases, and FBA bands in the 
320–470 nm region, as exemplified in Fig. 3. Upon excitation into the FBA band the tC-,  tCO-, and 2CNqA-
labeled gapmers display a broad unstructured emission in the 400–600 nm region, while the pA gapmers differ 
by having split emission bands and significantly smaller Stokes shifts. The complete set of absorption and emis-
sion spectra of all gapmers, both single-stranded and RNA-bound, are provided in Supplementary Fig. S19. 
Overall, both the absorption and emission features of the FBAs in the gapmers resemble those reported for the 
corresponding FBAs inside RNA and/or  DNA33–35,40,41. The spectra of the Cy3 gapmer are strongly reminiscent of 
what has been reported for Cy3 previously in several different  environments56. The gapmers’ emissive properties 
were further characterized by determining ΦF and τF (Fig. 4). 
The emissive properties of tC are known to be comparably insensitive to neighboring  bases41, which is also 
what is observed here, with ΦF and τF for the single-stranded tC gapmers ranging from 8.9%–11% and 4.8–5.6 ns, 
respectively (see Supplementary Fig. S19 and Table S1 for detailed fluorescence decay data). However, the ΦF 
observed for tC in the gapmer is substantially lower than those reported in ssDNA (< ΦF >  = 20%, < τF >  = 5.7 ns 
for mixed  neighbours41), which is surprising considering that a corresponding change in τF is not observed. This 
behavior could be explained by ground state quenching occurring in parts of the fluorophore population, but we 
also note that ΦF close to 10% has been suggested for tC in single-stranded RNA (ssRNA)  before57. In contrast 
to tC, the emissive properties of  tCO in single-stranded oligonucleotides have been shown to vary substantially 
depending on neighboring  bases33 and in  DNA33 compared to  RNA40. Here, we observe a ΦF of 23% and 21% 
for  tCO-1 and  tCO-2, respectively. Although this is moderately lower than what has been reported in ssDNA 
(< ΦF >  = 30% for mixed  neighbours33),  tCO-1 has the highest ΦF noted in this work. The adenine analogues 
2CNqA and pA both have thymines as neighboring bases in the herein investigated gapmer sequence (TG and/or 
TA neighbors), which is known to have a negative impact on ΦF for these  FBAs34,35. The 2CNqA-1 and 2CNqA-2 
gapmers exhibit ΦF of 22% and 12%, respectively, which is in fair agreement with the ΦF of 14%–15% reported in 
Figure 3.  Normalized UV–vis absorption spectra (solid lines) and emission spectra (dashed lines) of the tC-2 
(green),  tCO-2 (red), 2CNqA-2 (blue), pA-2 (black), and Cy3 (violet) gapmers.
Figure 4.  Fluorescence quantum yield (ΦF, red bars) and lifetime (τF, green bars) of the single-stranded (plain 
bars) and RNA-bound (striped bars) gapmers. Presented values are mean ± standard deviation from two 
independent replicates. The corresponding numeric data are provided in Supplementary Table S1.
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ssDNA with the same neighbors. The pA-labeled gapmers have comparably poor ΦF (1.9%–6.4%) although again 
consistent with previous reports for pA in  ssDNA35. The observation that ΦF for pA-2 is significantly lower than 
for pA-1TG and pA-1TA may indicate an interbase quenching interaction between the two FBA moieties in pA-2, 
which would agree with the findings of a slightly deviating duplex CD (vide supra). The ΦF for the Cy3 gapmer 
in this work was determined to 19%, which is in the low end of what has been reported for Cy3-labeled short 
oligomers (18%–39% in ssDNA, depending on sequence)58. Lastly, we analyzed the brightness of the gapmers 
(ΦF × molar absorptivity, Supplementary Fig. S18) and note that the highest ranking gapmer in this respect is 
 tCO-2, having 3,400  M-1  cm-1 and 1,100  M-1  cm-1 at the FBA band maximum (367 nm for  tCO-2) and at 405 nm, 
respectively. This is still significantly dimmer than Cy3 which, based on the ΦF determined here, has a maximum 
brightness that is approximately 8 times higher.
RNA‑bound gapmers. Studies aiming at quantifying uptake into cells and tissue by fluorescent means rely 
on fluorophores that maintain constant (or highly predictable) emissive properties, regardless of hybridization 
status, to report emission that is proportional to ASO concentration. If the goal instead is to study ASO-RNA 
interactions, a fluorophore arrangement that significantly increases in brightness, changes fluorescence lifetime, 
and/or displays a spectral shift upon duplex formation is preferred. To explore the FBA gapmers on these prem-
ises, we decided to investigate the photophysical properties after hybridization to form a heteroduplex with the 
fully complementary RNA. The ΦF and τF for the gapmer:RNA duplexes are shown in Fig. 4 (striped bars), while 
absorption and emission spectra, as well as fluorescence decays are shown in Supplementary Fig. S19. We find 
that RNA-binding has a minor effect on the emission characteristics of the tC gapmers, which is in line with the 
corresponding reports on homoduplex formation in  DNA41. For the  tCO gapmers, however, a small-to-moderate 
drop in ΦF is observed (4–8 percentage points), which again agrees with the small hybridization-induced changes 
observed for  tCO in DNA and RNA  homoduplexes33,40. For the 2CNqA gapmers, RNA binding brings about a 
small increase in ΦF and τF for 2CNqA-2, while a notable blue-shift of 6–8 nm is observed in the emission spec-
tra of both 2CNqA gapmers (Supplementary Fig. S19g–h). The 1.3-fold increase in ΦF observed for 2CNqA-2 
is, however, modest compared to the corresponding behavior of 2CNqA with one or two thymine neighbors 
in ssDNA, where ΦF increases by a factor of ca. 2–3 upon forming a  homoduplex34. The pA differs from the 
other FBAs in the gapmer environment by exhibiting a consistent increase in both ΦF and τF upon binding to 
the target RNA, with ΦF increasing by a factor of 1.3, 2.1, and 3.7 for pA-1TG, pA-1TA, and pA-2, respectively. A 
hybridization-induced increase in ΦF and τF of comparable magnitude has been reported for DNA-incorporated 
pA with one or two thymine neighbors  before35 and suggests that it may be possible to use fluorescence lifetime 
recording to detect target hybridization with pA-containing gapmer strands. The emissive properties of the Cy3 
gapmer are virtually unchanged upon RNA binding, suggesting that the end-grafted Cy3 moiety does not inter-
act with the base stack in this gapmer. In conclusion, we find representatives of two different types of labeling 
strategies among our gapmers, where for instance the tC and 2CNqA gapmers are fairly bright and insensitive to 
microenvironment, and thus suitable for fluorescence-based quantification, while pA-2, although having a low 
brightness as a single-strand, has the principal qualities of a hybridization probe, owing to its 3.7- and 3.4-fold 
increase in ΦF and τF, respectively, upon binding to RNA.
Cellular uptake of labeled gapmers. To demonstrate the applicability of the FBA-labeled gapmers in a 
biological context, we studied their uptake and localization in human embryonic kidney cells (HEK 293 T) using 
fluorescence microscopy and flow cytometry. For these experiments, we focused on the gapmers labeled with 
one or two FBAs in the gap, and on comparisons to the Cy3 gapmer. All gapmers were non-toxic to the cells at 
concentrations up to 3 µM, which is the highest dose applied in the live cell experiments, as shown by lack of 
lactate dehydrogenase (LDH) leakage after 24 h of incubation at 37 °C (Supplementary Fig. S25).
Fluorescence microscopy. We exposed cells to 3 µM unformulated gapmers for 24 h at 37 °C, where after the cells 
were immediately transferred to a stage-top incubator and imaged using a confocal microscope. The acquired 
images (Fig. 5; see Supplementary Fig. S26 for the corresponding data for the gapmers labeled with one FBA) 
show that the gapmers are internalized and accumulate inside the cells.
The observed punctuate intracellular fluorescence suggests that the uptake occurs occurred via endocytosis, 
resulting in vesicular localization of the gapmers, which is consistent with the recognized uptake process for oli-
gonucleotide  gymnosis59. We furthermore note that the punctuate distribution of FBA-labeled gapmers is similar 
to that of the Cy3 gapmer, suggesting that no significant difference in uptake route exist under the conditions 
applied here. To quantify the uptake of the FBA-labeled gapmers, we proceeded to study the dose-dependence 
of the uptake using flow cytometry (Fig. 6).
To correlate the mean fluorescence intensity signal (MFI) emanating from the cells in the flow cytometry 
experiment to gapmer concentration, we take into account the brightness and emission spectra of each FBA 
gapmer according to the procedure described in supplementary Sect. 3.5. This allowed us to compare the relative 
accumulation of the FBA-containing gapmers in the cells, as shown in Fig. 6. It should be noted that the herein 
presented uptake is based on total intracellular fluorescence, i.e. it does not distinguish between intra- and extra-
endosomal emission and therefore does not reflect functional (or productive) uptake. We observe that gapmer 
uptake increases with the applied dose, approaching saturation at the highest applied dose (3 µM, Fig. 6a). Judging 
by the difference in MFI of treated and untreated cells as well as the level of uncertainty in the cytometry data, it is 
clear that the brightness of the FBA-labeled gapmers is sufficient to reliably detect their uptake at an applied dose 
of 300 nM, despite the use of 405 nm excitation, which from a brightness perspective is suboptimal for all FBAs 
except tC (Supplementary Fig. S18). We furthermore observe that having two FBA incorporations, compared to 
one, leads to a small-to-moderate, albeit statistically significant (paired sample t-test, Fig. 6b), increase in uptake 
for  tCO, 2CNqA, and pA-1TG, but not for tC and pA-1TA. This could be due to the slight increase in lipophilicity 
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that result from the doubled aromatic moieties in the gapmer. The most striking feature of the flow cytometry 
data, however, is the distinctly higher uptake observed for the pA gapmers; in particular pA-2, which exhibit an 
uptake that is 3.0-fold higher than tC-2 and  tCO-2, and 7.4-fold higher than 2CNqA-2. It is noteworthy that the 
gapmers with the most pronounced uptake also are the ones for which a substantial fluorescence turn-on effect 
was observed upon binding to RNA: 2.1- and 3.7-fold for pA-1TA and pA-2, respectively (vide supra). However, 
Figure 5.  Confocal microscopy images of live HEK 293 T cells continuously exposed to unformulated gapmers 
(3 µM) for 24 h. Samples were excited at 405 nm (emission: 407–700 nm) for FBA detection and at 561 nm 
(emission: 563–700 nm) for Cy3 detection. Scale bars are 20 µm.
Figure 6.  Quantification of gapmer uptake in HEK 293 T cells after 24 h continuous exposure, evaluated 
using flow cytometry. All data were collected using the same excitation power (excitation at 405 nm) and 
detector settings. To enable comparisons of the FBA-labeled gapmer concentrations inside cells, a relative 
uptake was calculated based on the observed mean fluorescence intensity (MFI, see Supplementary Fig. S24 
for the untreated data). Briefly, this was achieved by (1) subtracting the corresponding MFI from the negative 
control (unmodified gapmer U at equal concentration), (2) dividing by the brightness of the single-stranded 
gapmer (B) and (3) dividing by a spectral correction factor (SCF), see supplementary Sect. 3.5 for details. (a) 
Dose-dependent relative uptake. (b) Relative uptake at the top concentration in (a). Error bars are propagated 
standard deviations (N = 6) based on the cytometry- and brightness data (Supplementary Fig. S18). *Probability 
for equal mean from a paired sample t-test.
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considering the punctuate distribution of ASOs inside the cells, we find it unlikely that a significant fraction of the 
gapmer population has escaped the endosomes and bound to RNA in our experiments. Nevertheless, it cannot 
be excluded that a hybridization-induced increase in ΦF to some extent contributes to an overestimated uptake 
for the pA gapmers. Studies on the pA monomer have revealed it to be relatively insensitive to solvent polarity: 
ΦF = 66%, 84%, and 74% in water, dimethyl sulfoxide, and toluene,  respectively35, which further suggests that 
the observed MFIs for the pA gapmers are unlikely to be skewed by environment-dependent effects, and rather 
reflect a difference in cell uptake. Finally, it should be noted that the complex relationship between total- and 
functional uptake of ASOs, which is intermediated by the highly elusive process of endosomal escape, is not fully 
 understood60,61. For instance, Linanne et al. showed in a recent study that cEt-modified gapmer gymnosis differs 
significantly across cancer cell lines and suggested that knockdown activity does not correlate with internalized 
 concentration62. Our observations are consistent with this notion since pA gapmers appear to have the highest 
uptake while also standing out from the rest of the FBA gapmers by exhibiting reduced knockdown activity. 
However, since neither endosomal escape nor RNase H1 processability are explicitly studied in this work, it is 
difficult to assess in which proportion the observed effect on MALAT1 knockdown can be attributed to differ-
ences in total uptake, gapmer:RNA secondary structure, and RNA affinity.
Conclusions
In this work, we synthesized modified versions of a 16 nt MALAT1-targeting gapmer containing the fluorescent 
base analogues (FBAs) tC,  tCO, 2CNqA, and pA, and systematically investigated the impact of FBA incorporation 
on RNA binding affinity, gapmer:RNA secondary structure, photophysical properties, and knockdown efficiency. 
To demonstrate the applicability of the FBA labeling approach, we also used the gapmers to study gymnotic 
uptake into human cells by means of live cell fluorescence microscopy and flow cytometry. We report that incor-
poration of one or two FBAs in the gap region of the gapmer does not lead to substantial changes in RNA affinity 
for any of the investigated FBAs. Moreover, the gapmer:RNA secondary structure is unaffected by the presence of 
the FBAs, except for slight deviations for 2CNqA-2 and pA-2. We furthermore demonstrate that FBA-labeling is 
a viable alternative to external dyes for live cell studies of gapmer uptake and that all investigated FBAs, despite 
exhibiting significantly lower brightness than commercial dyes, can readily be detected with a conventional 
confocal microscope. This is further highlighted by the results in flow cytometry, where administered gapmer 
concentrations down to at least 300 nM were clearly detectable inside the cells, even for the low-brightness pA-2. 
We also report a distinctly higher uptake of gapmers containing pA compared to the other FBAs, suggesting 
that pA may be interesting to explore further as a building block for enhancing ASO uptake. Finally, the qPCR 
data show that, except for the pA gapmers and the doubly labeled 2CNqA-2, FBA incorporations do not perturb 
the knockdown efficiency. This importantly demonstrate that the FBAs can be used in the biologically critical 
gap-region and that tC,  tCO, and 2CNqA in particular, are excellent mimics of their corresponding canonical 
bases in the gapmer environment. We foresee that FBAs will be further applied, not only as fluorescent probes 
for localization, but also in more advanced structural and mechanistic investigations involving ASOs and siRNA.
Data availability
The flow cytometry data are available at FlowRepository under repository ID FR-FCM-Z38. All other datasets 
generated and/or analyzed during the current study are available from the corresponding author on reasonable 
request.
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